Position in VERA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$119,889,982
+$7,487,885 QoQ
Shares Held
2,793,987
0.0% QoQ
Ownership
3.88%
of shares outstanding
% of Portfolio
6.41%
of 13F equity value
Holder Rank
#9
of 218 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sofinnova Investments, Inc. holds $1,182,454,857 across 43 Biotechnology names. VERA ranks #1 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VERA |
Vera Therapeutics, Inc.
This page
|
2,793,987 | $119,889,982 | |
| 2 | GMAB |
Genmab A/S
|
4,045,215 | $111,122,056 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
365,341 | $88,036,220 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
1,904,408 | $79,356,681 | |
| 5 | SPTX |
Seaport Therapeutics, Inc.
|
3,564,871 | $77,428,998 | |
| 6 | AVBP |
ArriVent BioPharma, Inc.
|
1,696,752 | $58,945,164 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,717,505 | $57,347,491 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
408,027 | $45,303,237 |
All Filings in VERA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,889,982 | 2,793,987 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $112,402,097 | 2,793,987 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $141,487,501 | 2,793,987 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $81,193,262 | 2,793,987 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $65,826,333 | 2,793,987 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $67,111,567 | 2,793,987 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $118,157,710 | 2,793,987 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $123,494,225 | 2,793,987 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $101,086,449 | 2,793,987 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $120,476,719 | 2,793,987 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $53,324,859 | 3,467,156 | Shares | Sole | 2024-08-15 | |
| 2023-09-30 | $47,534,708 | 3,467,156 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $55,647,853 | 3,467,156 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $26,905,130 | 3,467,156 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $61,560,902 | 3,181,442 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $67,796,529 | 3,181,442 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $43,299,425 | 3,181,442 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $74,732,072 | 3,181,442 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $77,882,814 | 2,914,776 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $50,571,363 | 2,914,776 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $38,649,929 | 2,914,776 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||